Scientifically speaking, its a glucagon-like peptide-1 (GLP-1) receptor agonist
According to the Centers for Disease Control (CDC), there are thirteen OACs: adenocarcinoma of the esophagus, post-menopausal breast cancer, colorectal cancer, uterine cancer, gallbladder cancer, upper stomach cancer, kidney cancer, ovarian cancer, pancreatic cancer, thyroid cancer, meningioma, and multiple myeloma
nonpharmacological weight management, according to study results
Svensson, C
Clinical trials show that participants can lose an average of 15 to 20 percent of their body weight over 72 weeks
After first use, room-temperature storage, when allowed, is not a blank check